Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100287052 | 10028705 | 2 | F | 20130719 | 20160912 | 20140321 | 20160915 | EXP | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-11915BP | BOEHRINGER INGELHEIM | 71.00 | YR | F | Y | 77.00000 | KG | 20160915 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100287052 | 10028705 | 1 | PS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 300 MG | 22512 | 150 | MG | BID | |||||||
| 100287052 | 10028705 | 2 | C | CELECOXIB. | CELECOXIB | 1 | Oral | 0 | TID | ||||||||||
| 100287052 | 10028705 | 3 | C | CELECOXIB. | CELECOXIB | 1 | 0 | ||||||||||||
| 100287052 | 10028705 | 4 | C | IBUPROFEN. | IBUPROFEN | 1 | Oral | 0 | TID | ||||||||||
| 100287052 | 10028705 | 5 | C | IBUPROFEN. | IBUPROFEN | 1 | 0 | ||||||||||||
| 100287052 | 10028705 | 6 | C | NAPROXEN. | NAPROXEN | 1 | Oral | 0 | TID | ||||||||||
| 100287052 | 10028705 | 7 | C | NAPROXEN. | NAPROXEN | 1 | 0 | ||||||||||||
| 100287052 | 10028705 | 8 | C | FENTANYL. | FENTANYL | 1 | Unknown | PATCHES | 0 | ||||||||||
| 100287052 | 10028705 | 9 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 20 MG | 0 | 20 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 100287052 | 10028705 | 1 | Atrial fibrillation |
| 100287052 | 10028705 | 2 | Osteoarthritis |
| 100287052 | 10028705 | 3 | Rheumatoid arthritis |
| 100287052 | 10028705 | 4 | Osteoarthritis |
| 100287052 | 10028705 | 5 | Rheumatoid arthritis |
| 100287052 | 10028705 | 6 | Osteoarthritis |
| 100287052 | 10028705 | 7 | Rheumatoid arthritis |
| 100287052 | 10028705 | 9 | Gastritis prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 100287052 | 10028705 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100287052 | 10028705 | Acute kidney injury | |
| 100287052 | 10028705 | Coagulopathy | |
| 100287052 | 10028705 | Colitis | |
| 100287052 | 10028705 | Haemorrhage | |
| 100287052 | 10028705 | Hypotension | |
| 100287052 | 10028705 | Intestinal obstruction | |
| 100287052 | 10028705 | Lactic acidosis | |
| 100287052 | 10028705 | Multiple organ dysfunction syndrome | |
| 100287052 | 10028705 | Rhabdomyolysis | |
| 100287052 | 10028705 | Shock |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 100287052 | 10028705 | 1 | 20110322 | 20130719 | 0 | |
| 100287052 | 10028705 | 2 | 20101005 | 20110312 | 0 | |
| 100287052 | 10028705 | 4 | 20101005 | 20110312 | 0 | |
| 100287052 | 10028705 | 6 | 20101005 | 20110312 | 0 | |
| 100287052 | 10028705 | 9 | 20101005 | 20110312 | 0 |